Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Profit 2010-2025 | MKKGY

Merck annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Merck gross profit for the quarter ending March 31, 2025 was $3.313B, a 1.42% increase year-over-year.
  • Merck gross profit for the twelve months ending March 31, 2025 was $13.556B, a 3.36% increase year-over-year.
  • Merck annual gross profit for 2024 was $13.51B, a 0.72% increase from 2023.
  • Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
  • Merck annual gross profit for 2022 was $14.44B, a 1.06% decline from 2021.
  
Merck Annual Gross Profit
(Millions of US $)
2024 $13,510
2023 $13,413
2022 $14,440
2021 $14,595
2020 $12,221
2019 $11,364
2018 $11,165
2017 $11,311
2016 $10,870
2015 $9,730
2014 $10,600
2013 $10,763
2012 $10,308
2011 $9,915
2010 $12,338
2009 $10,807
Merck Quarterly Gross Profit
(Millions of US $)
2025-03-31 $3,313
2024-12-31 $3,304
2024-09-30 $3,457
2024-06-30 $3,482
2024-03-31 $3,267
2023-12-31 $3,123
2023-09-30 $3,277
2023-06-30 $3,449
2023-03-31 $3,564
2022-12-31 $3,470
2022-09-30 $3,685
2022-06-30 $3,681
2022-03-31 $3,603
2021-12-31 $3,731
2021-09-30 $3,672
2021-06-30 $3,683
2021-03-31 $3,508
2020-12-31 $3,340
2020-09-30 $3,122
2020-06-30 $2,763
2020-03-31 $2,996
2019-12-31 $2,987
2019-09-30 $2,865
2019-06-30 $2,829
2019-03-31 $2,683
2018-12-31 $2,601
2018-09-30 $2,796
2018-06-30 $2,854
2018-03-31 $2,914
2017-12-31 $2,908
2017-09-30 $2,854
2017-06-30 $2,816
2017-03-31 $2,734
2016-12-31 $2,696
2016-09-30 $2,760
2016-06-30 $2,813
2016-03-31 $2,601
2015-12-31 $2,537
2015-09-30 $2,444
2015-06-30 $2,437
2015-03-31 $2,366
2014-12-31 $2,114
2014-09-30 $2,638
2014-06-30 $2,690
2014-03-31 $2,644
2013-12-31 $2,672
2013-09-30 $2,687
2013-06-30 $2,767
2013-03-31 $2,625
2012-12-31 $3,646
2012-09-30 $2,570
2012-06-30 $2,482
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $2,583
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $2,345
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.653B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.891B 28.47
Zoetis (ZTS) United States $67.311B 25.11
Takeda Pharmaceutical (TAK) Japan $46.297B 9.21
Daiichi Sankyo, - (DSNKY) Japan $45.521B 23.33
BeOne Medicines - (ONC) Cayman Islands $32.397B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.766B 0.00
Summit Therapeutics (SMMT) United States $19.710B 0.00
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.437B 11.89
Neurocrine Biosciences (NBIX) United States $13.138B 45.00
Orion OYJ (ORINY) Finland $11.666B 28.12
IPSEN (IPSEY) France $10.323B 0.00
Stevanato Group S.p.A (STVN) Italy $7.420B 45.37
Corcept Therapeutics (CORT) United States $7.326B 59.55
Madrigal Pharmaceuticals (MDGL) United States $6.959B 0.00
Ionis Pharmaceuticals (IONS) United States $6.677B 0.00
Grifols, S.A (GRFS) Spain $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.335B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
Hypermarcas (HYPMY) Brazil $3.034B 19.96
Crinetics Pharmaceuticals (CRNX) United States $2.853B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.574B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.549B 8.93
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
Centessa Pharmaceuticals (CNTA) United Kingdom $2.160B 0.00
Ocular Therapeutix (OCUL) United States $1.840B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.810B 0.00
ARS Pharmaceuticals (SPRY) United States $1.728B 0.00
Endo (NDOI) United States $1.603B 0.00
Harrow (HROW) United States $1.325B 0.00
Evotec AG (EVO) Germany $1.321B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.200B 24.00
Avadel Pharmaceuticals (AVDL) Ireland $1.086B 0.00
Ardelyx (ARDX) United States $1.059B 0.00
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.047B 0.00
Collegium Pharmaceutical (COLL) United States $1.017B 5.48
Akebia Therapeutics (AKBA) United States $1.011B 0.00
Verve Therapeutics (VERV) United States $0.988B 0.00
ProKidney (PROK) United States $0.893B 0.00
Cronos Group (CRON) Canada $0.825B 0.00
Xeris Biopharma Holdings (XERS) United States $0.801B 0.00
KalVista Pharmaceuticals (KALV) United States $0.790B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.702B 0.00
Xencor (XNCR) United States $0.655B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Zevra Therapeutics (ZVRA) United States $0.633B 0.00
Organogenesis (ORGO) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.589B 0.00
USANA Health Sciences (USNA) United States $0.587B 11.81
Theravance Biopharma (TBPH) United States $0.562B 0.00
Bioventus (BVS) United States $0.529B 13.42
Oruka Therapeutics (ORKA) United States $0.526B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.484B 0.00
Savara (SVRA) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 9.69
Altimmune (ALT) United States $0.341B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
AleAnna (ANNA) United States $0.307B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.37
OmniAb (OABI) United States $0.252B 0.00
Esperion Therapeutics (ESPR) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.240B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
China SXT Pharmaceuticals (SXTC) China $0.204B 0.00
Galectin Therapeutics (GALT) United States $0.181B 0.00
Profound Medical (PROF) Canada $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.175B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Lyell Immunopharma (LYEL) United States $0.152B 0.00
Liminatus Pharma (LIMN) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.143B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Cassava Sciences (SAVA) United States $0.125B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.83
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Nutriband (NTRB) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Fractyl Health (GUTS) United States $0.091B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.074B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.78
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.026B 0.00
Incannex Healthcare (IXHL) Australia $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.41
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.46
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00